| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.1 |